Oskar Komisarek

Dr. Oskar Komisarek

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 May 2020 in Journal of Cosmetic Dermatology
Verified
Journal Article
Closed access
PDF file
PBPatrycja Bartkowska
Patrycja Bartkowska
OKOskar Komisarek
Oskar Komisarek

18 September 2020 in Indian Journal of Otolaryngology and Head & Neck Surgery
Verified
Journal Article
Open access
PDF file
BWBartosz Wojtera
Bartosz Wojtera
AWAngelika Woźna
Angelika Woźna
OKOskar Komisarek
Oskar Komisarek
Displacement of foreign bodies into the maxillary sinus shows an increasing tendency, especially in regard to raising amount of dental implant installation procedures. The purpose of our study was to compare the efficiency and the rate of late complications among the methods of removal of foreign bodies from maxillary sinus. We performed a systematic review following PRISMA Checklist, searching Pubmed and Google Scholar databases for studies investigating the methods of removal of foreign bodies from maxillary sinus. The inclusion criteria embraced the examined group of at least 10 cases and the follow up period of minimum 3 months. We qualified 7 papers from 531 identified in primary search. Among qualified studies functional endoscopic sinus surgery used in order to remove foreign body from maxillary sinus had no late complications, whereas they occurred in 0–5% cases of using replaceable or pedicled bone approaches and in 15–18% cases of Caldwell-Luc approach. FESS probably should become a gold standard in retrieving foreign bodies from maxillary sinus, however poor evidence requires further investigation, especially in prospective, randomized trials.

11 December 2018 in Neurologia i Neurochirurgia Polska
Verified
Journal Article
Closed access
HOHubert Ostrowski
Hubert Ostrowski
JRJustyna Roszak
Justyna Roszak
OKOskar Komisarek
Oskar Komisarek
Introduction. Trigeminal neuralgia (TN) is one of the most common neurological diseases involving the orofacial region. It affects mainly the older population, usually after the age of 60, and more commonlywomen. It involves the fifth cranial nerve and manifests as paroxysmal, unilateral, severe, shock-like or knife-like pain of from a second to two minutes' duration. Usually pain attacks arise spontaneously, but they can also be precipitated by triggers such as cold weather, brushing teeth or shaving. The ICHD-3 classification divides TN into classical, secondary and idiopathic. Current treatment includes pharmacological and surgical methods. Anticonvulsants, such as carbamazepine and oxcarbazepine, are the first line therapy. Microvascular decompression is the most common and most effective way to treat TN surgically. However, none of these methods is free from complications. Moreover, 25-50% of patients became refractory to drug therapy. Some studies have shown that a new therapy that uses a Botulinum toxin type A can be a safe and effective way to treat trigeminal neuralgia. Methods. Literature from the PubMed base and the Main Medical Library from the last 18 years was analysed. Forty-three items were obtained; after verification, seven articles were included. Aim of the study.To look at current guidelines about treating trigeminal neuralgia with Botulinum Toxin type A in patients who are refractory to drug therapy or who do not want to undergo surgical treatment. Conclusion. BoNT-A therapy is a safe and effective method of treating trigeminal neuralgia.

12 July 2020 in Journal of Cosmetic Dermatology
Verified
Journal Article
Closed access
PDF file
PBPatrycja Bartkowska
Patrycja Bartkowska
JRJustyna Roszak
Justyna Roszak
HOHubert Ostrowski
Hubert Ostrowski
OKOskar Komisarek
Oskar Komisarek

20 April 2023 in Cancer Investigation
Verified
Journal Article
Closed access
AŚAleksandra Śledzińska
Aleksandra Śledzińska
PŚPaulina Śledzińska-Bebyn
Paulina Śledzińska-Bebyn
MBMarek Bebyn
Marek Bebyn
OKOskar Komisarek
Oskar Komisarek
Cancer is currently a significant therapeutic challenge and is frequently connected with numerous adverse effects. Despite many improvements in chemotherapy, oral complications are common, leading to poor quality of life and chemotherapeutic dose reduction, which impair survival. This review summarizes the most common dental complications in patients receiving chemotherapy. We mainly focus on oral mucositis as it is a major cause of dose-limiting toxicity. Furthermore, oral candidiasis, viral infections, and xerostomia will be discussed. Conclusions: preventing complications is significantly more important than treating them. All patients beginning systemic anticancer treatment should undergo a thorough oral examination and get appropriate prophylaxis.

28 June 2022 in Brain Sciences
Verified
Journal Article
Open access
PDF file
Roksana MalakRoksana Malak
Roksana Malak
KWKatarzyna Wiecheć
Katarzyna Wiecheć
BFBrittany Fechner
Brittany Fechner
TSTomasz Szczapa
Tomasz Szczapa
JKJoanna Kasperkowicz
Joanna Kasperkowicz
EMEwa Mojs
Ewa Mojs
The diagnosis of neurobehavioral problems in very preterm neonates helps with planning and applying proper and direct therapeutic interventions. (1) Background: The aim of this study was to determine the direct impact of neurobehavior on the sucking reflex and eating abilities of neonates. (2) Methods: We assessed 18 preterm neonates twice hospitalized at the Gynecology and Obstetrics Clinical Hospital through the use of the Neonatal Behavioral Assessment Scale (NBAS). (3) Results: We found that that a neonate’s sucking ability positively correlated with the activity level item from the motor system cluster of the NBAS. (4) Conclusions: Neurobehavior should be closely assessed in very preterm neonates. Firstly, because assessments can detect fundamental problems and help a practitioner plan for early intervention. Secondly, the education of parents regarding the neurobehavior of their child can help in the facilitation of feeding skills and the planning of early rehabilitation.